Out of 336 initial submissions across both Business and NPO Tracks, DiaTheris is the winner of Switzerland's leading early-stage startups...

L'università di Ginevra lavora su una terapia alternativa basata sulla proteina S100A9, che può regolare la glicemia, i chetoni e i...

Unrestrained ketogenesis leads to life-threatening ketoacidosis whose incidence is high in patients with diabetes. While insulin therapy...

A UNIGE team reveals how the S100A9 protein improves metabolism of insulin-dependent diabetics by avoiding the deleterious effects of...